GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA ...

The National Council on Aging reveals that about 30 million people in the US have sleep apnea, but only six million of these people have actually been diagnosed. Sleep apnea is a disorder that causes ...

The makers of the weight loss drug tirzepatide, which is branded commercially as Zepbound, announced Wednesday the results of a Phase 3 study showing that the drug was effective in treating sleep ...

About half of people who are prescribed the gold-standard treatment stop using it. The treatment, a continuous positive airway pressure, or CPAP, device keeps the airway open, but many find it loud ...

FILE - A woman demonstrates how she puts on her sleep apnea breathing device at her home in Los Angeles Thursday, July 12, 2018. Tirzepatide, used to treat diabetes and obesity, can help with sleep ...

New research shows obstructive sleep apnea severity increases 18% on weekends compared to weekdays. A sleep expert discusses ...